The efficacy of myo-inositol supplementation to reduce the incidence of gestational diabetes: a meta-analysis

References

• Wei W, He Y, Wang X, et al. Gestational diabetes mellitus: the genetic susceptibility behind the disease. Horm Metab Res. 2021;53(8):489–498.
   PubMedGoogle Scholar
• Zhang C, Catalano P. Screening for gestational diabetes. JAMA. 2021;326(6):487–489.
   PubMedGoogle Scholar
• Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–1779.
   PubMed Web of Science ®Google Scholar
• Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115(3):e290–e296.
   PubMed Web of Science ®Google Scholar
• Johns EC, Denison FC, Norman JE, et al. Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends Endocrinol Metab. 2018;29(11):743–754.
   PubMed Web of Science ®Google Scholar
• Goldstein RF, Abell SK, Ranasinha S, et al. Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. Jama. 2017;317(21):2207–2225.
   PubMed Web of Science ®Google Scholar
• McIntyre HD, Catalano P, Zhang C, et al. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47.
   PubMed Web of Science ®Google Scholar
• Mack LR, Tomich PG. Gestational diabetes: diagnosis, classification, and clinical care. Obstet Gynecol Clin North Am. 2017;44(2):207–217.
   PubMed Web of Science ®Google Scholar
• Moon JH, Kwak SH, Jang HC. Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus. Korean J Intern Med. 2017;32(1):26–41.
   PubMed Web of Science ®Google Scholar
• Rogozińska E, Chamillard M, Hitman GA, et al. Nutritional manipulation for the primary prevention of gestational diabetes mellitus: a Meta-analysis of randomised studies. PloS One. 2015;10(2):e0115526.
   PubMedGoogle Scholar
• Vitagliano A, Saccone G, Cosmi E, et al. Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials. Arch Gynecol Obstet. 2019;299(1):55–68.
   PubMed Web of Science ®Google Scholar
• Corrado F, D’Anna R, Vieste GD, et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med. 2011;28(8):972–975.
   PubMed Web of Science ®Google Scholar
• Matarrelli B, Vitacolonna E, D’angelo M, et al. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2013;26(10):967–972.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Corrado F, Caruso S, et al. Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial. Int J Food Sci Nutr. 2021;72(5):670–679.
   PubMed Web of Science ®Google Scholar
• Celentano C, Matarrelli B, Pavone G, et al. The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial. J Matern Fetal Neonatal Med. 2020;33(5):743–751.
   PubMedGoogle Scholar
• Farren M, Daly N, McKeating A, et al. The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial. Diabetes Care. 2017;40(6):759–763.
   PubMed Web of Science ®Google Scholar
• Santamaria A, Benedetto AD, Petrella E, et al. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. J Matern Fetal Neonatal Med. 2016;29(19):3234–3237.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Sally G. Cochrane handbook for systematic reviews of interventions version 5.1.0. [updated March 2011]. The cochrane collaboration (2011).
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–1012.
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.
   PubMedGoogle Scholar
• Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in Meta-Analyses. Ann Intern Med. 2001;135(11):982–989.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist. Med. 2002;21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• D’Anna R, Benedetto AD, Scilipoti A, et al. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial. Obstet Gynecol. 2015;126(2):310–315.
   PubMed Web of Science ®Google Scholar
• D’Anna R, Scilipoti A, Giordano D, et al. myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care. 2013;36(4):854–857.
   PubMed Web of Science ®Google Scholar
• Amaefule CE, Drymoussi Z, Gonzalez Carreras FJ, et al. Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study. BMJ Open. 2022;12(3):e050110.
   PubMedGoogle Scholar
• Schwartz N, Green MS, Yefet E, et al. Modifiable risk factors for gestational diabetes recurrence. Endocrine. 2016;54(3):714–722.
   PubMedGoogle Scholar
• Spaight C, Gross J, Horsch A, et al. Gestational diabetes mellitus. Endocr Dev. 2016;31:163–178.
   PubMedGoogle Scholar
• BE M, DR C. Proceedings of the 4th International Workshop-Conference on Gestational Diabetes Mellitus. Chicago, Illinois, USA. 14–16 March 1997. Diabetes Care. 1998;21 Suppl 2:B1–167.
   PubMedGoogle Scholar
• Dominguez-Vigo P, Alvarez-Silvares E, Alves-Perez MT, et al. Incidence and clinical risk factors for the development of diabetes mellitus in women with previous gestational diabetes. Ginecol Obstetr Mexico. 2016;84(4):228–242.
   PubMedGoogle Scholar
• Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep. 2016;16(1):7.
   PubMed Web of Science ®Google Scholar
• Rasmussen L, Poulsen CW, Kampmann U, et al. Diet and healthy lifestyle in the management of gestational diabetes mellitus. Nutrients. 2020;12(10):3050.
   PubMed Web of Science ®Google Scholar
• Larner J, Brautigan DL, Thorner MO. D-chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med. 2010;16(11–12):543–552.
   PubMed Web of Science ®Google Scholar
• Costabile L, Unfer V. Treatment of gestational diabetes mellitus with myo-inositol: analyzing the cutting edge starting from a peculiar case. Eur Rev Med Pharmacol Sci. 2017;21(2 Suppl):73–76.
   PubMedGoogle Scholar
• Fraticelli F, Celentano C, Zecca IA, et al. Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial. Acta Diabetol. 2018;55(8):805–812.
   PubMed Web of Science ®Google Scholar
• Miñambres I, Cuixart G, Gonçalves A, et al. Effects of inositol on glucose homeostasis: systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2019;38(3):1146–1152.
   PubMed Web of Science ®Google Scholar
• Gambioli R, Forte G, Buzzaccarini G, et al. Myo-Inositol as a key supporter of fertility and physiological gestation. Pharmaceuticals (Basel, Switzerland). 2021;14(6):504.
   PubMedGoogle Scholar
• Michell RH. The multiplying roles of inositol lipids and phosphates in cell control processes. Essays Biochem. 1997;32:31–47.
   PubMed Web of Science ®Google Scholar
• Saltiel AR. Second messengers of insulin action. Diabetes Care. 1990;13(3):244–256.
   PubMed Web of Science ®Google Scholar
• Muscogiuri G, Palomba S, Lagana AS, et al. Inositols in the treatment of insulin-mediated diseases. Int J Endocrinol. 2016;2016:3058393.
   PubMed Web of Science ®Google Scholar
• D’Anna R, Corrado F, Loddo S, et al. Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study. Sci Rep. 2021;11(1):8866.
   PubMedGoogle Scholar
• Morgante G, Massaro MG, Sabatino AD, et al. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecol Endocrinol. 2018;34(1):4–9.
   PubMed Web of Science ®Google Scholar
• Giordano D, Corrado F, Santamaria A, et al. Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. Menopause. 2011;18(1):102–104.
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Cavalli P, Copp AJ, et al. An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs). Expert Opin Drug Metab Toxicol. 2020;16(12):1187–1198.
   PubMed Web of Science ®Google Scholar